2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal SubtypeAdvanced Breast Cancer; Advanced Breast Carcinoma; Hormone Receptor Positive Breast CarcinomaRecruitingPhase 22026-07-30NCT06486883
International Multicentric Retrospective Study on the Use of EV+P as First-line Therapy in Patients With la/mUCLocally Advanced or Metastatic Urothelial Cancer; Urothelial CancerNot yet recruitingNot stated2026-02-19NCT07420855